Positive troponin-T in noncompaction is associated with neuromuscular disorders and poor outcome

J Finsterer1, C Stöllberger, W Krugluger

  • 1Krankenanstalt Rudolfstiftung, Vienna, Austria. dvarte@aonmail.at

Insights

Cardiac troponin-T is positive in 17% of patients with left ventricular hypertrabeculation/noncompaction (LVHT). This positivity often indicates an underlying neuromuscular disorder (NMD) and predicts poorer survival in LVHT patients.

Area of Science:

  • Cardiology
  • Neurology
  • Biomarkers

Background:

  • Left ventricular hypertrabeculation/noncompaction (LVHT) is an unclassified cardiomyopathy.
  • Elevated cardiac troponin-T is observed in other cardiomyopathies, but its prevalence in LVHT is unknown.
  • Investigating troponin-T in LVHT is crucial for understanding its etiology and prognostic implications.

Purpose of the Study:

  • To determine the frequency of positive troponin-T in patients with LVHT.
  • To assess the association of troponin-T positivity with elevated creatine kinase (CK).
  • To identify cardiac and extra-cardiac causes, particularly neuromuscular disorders (NMDs), of troponin-T positivity and evaluate its predictive value for survival.

Main Methods:

  • Retrospective analysis of 100 patients diagnosed with LVHT over 11 years.
  • Troponin-T levels were measured at least once in 71 patients.
  • Correlation of troponin-T results with CK levels, cardiac conditions, NMDs, and survival data.

Main Results:

  • Troponin-T was positive at least once in 17% of LVHT patients.
  • A significant proportion of patients (63%) had an associated NMD.
  • Troponin-T positivity was linked to NMD (10 cases), chronic renal failure (5 cases), and dilated cardiomyopathy (4 cases).
  • Troponin-T positivity predicted the presence of NMD and was associated with poorer survival.

Conclusions:

  • Troponin-T elevation occurs in 17% of LVHT patients.
  • The majority of patients with positive troponin-T have an underlying NMD.
  • Troponin-T positivity in LVHT serves as a predictor for NMD and adverse survival outcomes.
Abstract

Related Concept Videos

Myasthenia Gravis: Diagnostic Tests01:15

Myasthenia Gravis: Diagnostic Tests

Myasthenia gravis is an autoimmune condition affecting neuromuscular transmission, causing generalized weakness in skeletal muscles. Initial diagnoses rely on patients' signs, symptoms, and medical history. The challenge lies in distinguishing myasthenia from other muscular dystrophies. An important diagnostic feature is the significant improvement of symptoms after administering anticholinesterase inhibitors.
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
Alterations in Muscle Tone lll01:11

Alterations in Muscle Tone lll

Rigidity and myotonia are distinct abnormalities of muscle tone that affect resistance and relaxation during movement. Although both involve altered muscle contraction, they arise from different neurological and muscular mechanisms.CharacteristicsRigidity is characterized by uniform resistance to passive movement across the entire range, independent of speed, affecting flexors and extensors equally. It may appear as lead-pipe rigidity (smooth, constant resistance) or cogwheel rigidity...
Alterations in Muscle Tone ll01:12

Alterations in Muscle Tone ll

Alterations in muscle tone are common manifestations of neurological disorders and reflect dysfunction within different nervous system regions. Spasticity, paratonia, and dystonia represent distinct forms of hypertonia, each with unique mechanisms, clinical features, and diagnostic importance.CharacteristicsSpasticity happens from upper motor neuron lesions and is characterized by velocity-dependent resistance to passive movement. Clinical features include:Exaggerated deep tendon reflexesClonus...
Disorders of the Skeletal Muscle01:28

Disorders of the Skeletal Muscle

The clinical conditions affecting the skeletal muscle tissue are broadly categorized as musculoskeletal and neuromuscular disorders.
Musculoskeletal disorders
Musculoskeletal disorders involve injuries and conditions affecting the skeletal muscles and associated connective tissues. These disorders can arise from acute biomechanical stresses or chronic overuse and can occur across different age groups. Common injuries include sprains, fractures, and muscular strains, often resulting from...
Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
Tetanus01:29

Tetanus

Tetanus is a life-threatening neurological disorder characterized by persistent muscle contractions and spastic paralysis. It is caused by Clostridium tetani, a motile, Gram-positive, rod-shaped, obligate anaerobe. These bacteria produce terminal endospores, giving them a distinctive “lollipop” or “tennis-racket” appearance. They thrive in anaerobic environments, such as those found in deep puncture wounds.Once introduced into the body, the spores germinate into vegetative cells. These cells...